Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.42 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.34 |
| ▸ | NPY1R | P25929 | 1/20 | 0.34 |
| ▸ | NPFFR1 | Q9GZQ6 | 1/20 | 0.34 |
| ▸ | PPID | Q08752 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | TRAP1 | Q12931 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL20874210 | 1.00 | NOD1 (0.42) | NOD1GLO1KMT2ATLR7NPY1R | |
| Bromide SCHEMBL20874287 | 0.99 | NOD1 (0.41) | NOD1GLO1KMT2ATLR7NPY1R | |
| Bromide SCHEMBL20874258 | 0.99 | NOD1 (0.41) | NOD1GLO1KMT2ATLR7NPY1R | |
| Bromide SCHEMBL20874250 | 0.97 | NOD1 (0.40) | NOD1GLO1KMT2ATLR7NPY1R | |
| Bromide SCHEMBL20874252 | 0.97 | NOD1 (0.40) | NOD1GLO1KMT2ATLR7NPY1R | |
| Bromide SCHEMBL20874204 | 0.93 | GLO1 (0.40) | NOD1GLO1PPIDMMEANPEP | |
| Bromide SCHEMBL20874202 | 0.93 | GLO1 (0.40) | NOD1GLO1PPIDMMEANPEP | |
| Bromide SCHEMBL20874243 | 0.91 | GLO1 (0.40) | NOD1GLO1KMT2A | |
| Bromide SCHEMBL20874393 | 0.91 | GLO1 (0.40) | NOD1GLO1KMT2A | |
| Bromide SCHEMBL20874230 | 0.90 | TLR7 (0.40) | NOD1GLO1TLR7MMEANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3468563-B1 | COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME | UNIV OREGON STATE (US) | 2023-09-13 | — | — | EP | disclosed |
| US-20190106456-A1 | COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME | OREGON STATE UNIVERSITY (US) | 2019-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190106456-A1 | COMPOUNDS FOR DELIVERING GLUTATHIONE TO A TARGET AND METHODS OF MAKING AND USING THE SAME | GSR, TXN2, GLS | NOD1 3585/4885GLO1 106/4885KMT2A 3743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.